<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02732704</url>
  </required_header>
  <id_info>
    <org_study_id>CP-0004</org_study_id>
    <secondary_id>P02C320_JV06EFS_CIP</secondary_id>
    <secondary_id>CA-0002 EU</secondary_id>
    <secondary_id>CA-0002 Germany</secondary_id>
    <secondary_id>CA-0011</secondary_id>
    <nct_id>NCT02732704</nct_id>
  </id_info>
  <brief_title>THE ALIGN-AR TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study</brief_title>
  <official_title>THE ALIGN-AR TRIAL: Safety and Effectiveness/Performance of the Transfemoral JenaValve Pericardial TAVR System in the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>JenaValve Technology, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cardiovascular Research Foundation, New York</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>JenaValve Technology, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To collect information about treatment for severe Aortic Regurgitation (AR), which affects
      the aortic valve in the heart. Aortic regurgitation is a condition where aortic valve in the
      heart does not close tightly and allows some blood to leak back into the heart chamber.
      Symptoms of aortic regurgitation may include fatigue and shortness of breath. The preferred
      treatment for severe aortic regurgitation is aortic valve replacement surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will examine the use of TAVR (Transcatheter Aortic Valve Replacement), which is a
      minimally invasive procedure designed to replace the aortic valve inside the heart. In this
      study, TAVR will be performed using the JenaValve Pericardial TAVR System, which is intended
      to help treat severe aortic regurgitation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 20, 2018</start_date>
  <completion_date type="Anticipated">June 2025</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All-Cause Mortality at 30 days</measure>
    <time_frame>30 days</time_frame>
    <description>All-Cause mortality within the first 30 days post index procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>At 30 days</time_frame>
    <description>Absence of procedural mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peri-Procedural Myocardial Infarction</measure>
    <time_frame>At ≤72hr after the index procedure</time_frame>
    <description>Peri-procedural and spontaneous myocardial infarction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke-Free Survival</measure>
    <time_frame>At 30 days and 1 year</time_frame>
    <description>Disabling or non-disabling stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding &amp; Vascular Complications</measure>
    <time_frame>30 days</time_frame>
    <description>Major and minor bleeding</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Aortic Regurgitation</condition>
  <arm_group>
    <arm_group_label>Transcatheter Aortic Valve Replacement (TAVR)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TAVR with JenaValve Pericardial Valve and Delivery System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>JenaValve Pericardial TAVR System</intervention_name>
    <description>TAVR with JenaValve Pericardial Valve and Delivery System</description>
    <arm_group_label>Transcatheter Aortic Valve Replacement (TAVR)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with severe aortic regurgitation (AR).

          -  Patient at high risk for open surgical valve replacement

          -  Patient symptomatic according to NYHA functional class II or higher

          -  The study patient has been informed of the nature of the study, agrees to its
             provisions and has provided written informed consent as approved by the Institutional
             Review Board (IRB)/ Ethics Committee (EC) of the respective clinical site.

        Exclusion Criteria:

          -  Congenital uni or bicuspid aortic valve morphology

          -  Previous prosthetic aortic valve (bioprosthesis or mechanical) implant

          -  Endocarditis or other active infection

          -  Need for urgent or emergent TAVR procedure for any reason

          -  Cardiogenic shock or hemodynamic instability requiring inotropic support or
             ventricular assist device

          -  Severe mitral regurgitation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin B. Leon, MD</last_name>
    <role>Study Chair</role>
    <affiliation>New York-Presbyterian/ Columbia University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Torsten P. Vahl, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York-Presbyterian/ Columbia University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vinod H. Thourani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Piedmont Healthcare</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stephan Baldus, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Herzzentrum der Universität zu Köln</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vinny Podichetty</last_name>
    <phone>9493967510</phone>
    <email>podichetty@jenavalve.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cedars Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mitch Gheorghiu</last_name>
      <phone>310-423-6152</phone>
      <email>Mitch.Gheorghiu@cshs.org</email>
    </contact>
    <investigator>
      <last_name>Raj Makkar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>California Pacific Medical Center Research Institute</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Milena Ferreira</last_name>
      <phone>415-600-5707</phone>
      <email>ferreiml@sutterhealth.org</email>
    </contact>
    <investigator>
      <last_name>David V. Daniels, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MedStar Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erin Collins</last_name>
      <phone>202-877-6622</phone>
      <email>Erin.C.Collins@medstar.net</email>
    </contact>
    <investigator>
      <last_name>Ron Waksman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Piedmont Healthcare</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimi Wang</last_name>
      <phone>404-605-5699</phone>
      <email>kimi.wang@piedmont.org</email>
    </contact>
    <investigator>
      <last_name>Christopher U. Meduri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Charles</last_name>
      <phone>678-778-7706</phone>
      <email>echarl2@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Adam B. Greenbaum, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Oakley</last_name>
      <phone>734-232-9051</phone>
      <email>joakley@med.umich.edu</email>
    </contact>
    <investigator>
      <last_name>Stanley J. Chetcuti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rutgers State University</name>
      <address>
        <city>Piscataway</city>
        <state>New Jersey</state>
        <zip>08854</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Susette Coyle</last_name>
      <phone>732-235-8142</phone>
      <email>coylesu@rwjms.rutgers.edu</email>
    </contact>
    <investigator>
      <last_name>Mark J. Russo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York-Presbyterian/ Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Borden</last_name>
      <phone>212-342-5129</phone>
      <email>sb1097@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Torsten P. Vahl, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor Scott &amp; White Research Institute</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Necole Kell</last_name>
      <phone>469-817-4720</phone>
      <email>necole.kell@bswhealth.org</email>
    </contact>
    <investigator>
      <last_name>Molly Szerlip, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kate Jordan</last_name>
      <phone>206-616-6768</phone>
      <email>jordank1@cardiology.washington.edu</email>
    </contact>
    <investigator>
      <last_name>James McCabe, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kerckhoff-Klinik GmbH Bad Nauheim</name>
      <address>
        <city>Bad Nauheim</city>
        <zip>61231</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Herz- und Diabeteszentrum NRW Ruhr-Universität Bochum Bad Oeynhausen</name>
      <address>
        <city>Bad Oeynhausen</city>
        <zip>32545</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Deutsches Herzzentrum Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Bonn</name>
      <address>
        <city>Bonn</city>
        <zip>53127</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <zip>60323</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitäres Herzzentrum Hamburg</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Herzzentrum der Universität zu Köln</name>
      <address>
        <city>Köln</city>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Leiden University Medical Center</name>
      <address>
        <city>Leiden</city>
        <zip>2333</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>St. Antonius Hospital</name>
      <address>
        <city>Nieuwegein</city>
        <zip>3435</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Erasmus University Medical Center</name>
      <address>
        <city>Rotterdam</city>
        <zip>3062</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Waikato Hospital</name>
      <address>
        <city>Hamilton</city>
        <zip>3240</zip>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Netherlands</country>
    <country>New Zealand</country>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>March 18, 2016</study_first_submitted>
  <study_first_submitted_qc>April 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 11, 2016</study_first_posted>
  <last_update_submitted>June 2, 2020</last_update_submitted>
  <last_update_submitted_qc>June 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aortic Valve Disease</keyword>
  <keyword>Aortic Regurgitation</keyword>
  <keyword>Aortic Insufficiency</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

